Q32 Bio issues pre-funded warrants to purchase common stock
Q32 Bio Inc. filed an 8-K exhibiting pre-funded warrant terms dated May 26, 2026, allowing holders to purchase common shares at specified exercise prices. The offering expands the company's capital raising toolkit through derivative securities.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day